Evidence map›Paper›PMID 22322073›Full record

ReviewNeuroscience letters2012

Building stem cell niches from the molecule up through engineered peptide materials.

Kyle J Lampe, Sarah C Heilshorn

Abstract readReview
In one paragraph

Review in Neuroscience letters, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Bioscaffold-Induced Brain Tissue Regeneration.Frontiers in neuroscience · 2019
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kyle J LampeMaterials Science and Engineering, 476 Lomita Mall, Stanford University, Stanford, CA 94305, USA. klampe@stanford.edu
Sarah C Heilshorn

Funding

Engineering 3D in vitro niches to reveal fundamentals of cellular biomechanicsDP2OD006477 · OD · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C · 2009 to 2009
$2.4M
A combined drug and neural stem cell delivery approach for treating strokeF32NS076222 · NINDS · STANFORD UNIVERSITY · PI LAMPE, KYLE J. · 2011 to 2013
$121k
NIH HHS DP2 OD006477NIH HHS DP2-OD-006477NINDS NIH HHS F32 NS076222
6 · The paper itself

Abstract

The native stem cell niche is a dynamic and complex microenvironment. Recapitulating this niche is a critical focus within the fields of stem cell biology, tissue engineering, and regenerative medicine and requires the development of well-defined, tunable materials. Recent biomaterial design strategies seek to create engineered matrices that interact with cells at the molecular scale and allow on-demand, cell-triggered matrix modifications. Peptide and protein engineering can accomplish these goals through the molecular-level design of bioinductive and bioresponsive materials. This brief review focuses on engineered peptide and protein materials suitable for use as in vitro neural stem cell niche mimics and in vivo central nervous system repair. A key hallmark of these materials is the immense design freedom to specify the exact amino acid sequence leading to multi-functional bulk materials with tunable properties. These advanced materials are engineered using rational design strategies to recapitulate key aspects of the native neural stem cell niche. The resulting materials often combine the advantages of biological matrices with the engineering control of synthetic polymers. Future design strategies are expected to endow these materials with multiple layers of bi-directional feedback between the cell and the matrix, which will lead to more advanced mimics of the highly dynamic neural stem cell niche.

Indexed as

Protein EngineeringStem Cell NicheTissue EngineeringAnimalsBiomimetic MaterialsCell Culture TechniquesClinical Trials as TopicDrug Delivery SystemsExtracellular MatrixHumansHydrogelsNeural Stem CellsPeptidesProteinsHydrogelsPeptidesProteins

Identifiers

PMID22322073
PMCPMC3691058

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.